Tat (47-57)

General Information


DRACP ID  DRACP00070

Peptide Name   Tat (47-57)

Sequence  YGRKKRRQRRR

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Transducing peptide Cell-penetrating peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 55-65% viablity=100 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00070

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C64H118N32O14

Absent amino acids  ACDEFHILMNPSTVW

Common amino acids  R

Mass  173837

Pl  12.81

Basic residues  8

Acidic residues  0

Hydrophobic residues  0

Net charge  8

Boman Index  -10536

Hydrophobicity  -363.64

Aliphatic Index  0

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  149

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12417587

Title  Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes

Doi 10.1074/jbc.M208762200

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.